AI assistant
Sending…
LISATA THERAPEUTICS, INC. — Director's Dealing 2016
Nov 10, 2016
34931_dirs_2016-11-10_47a9546a-1fdd-4f19-b8c5-77903cd58ee8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Caladrius Biosciences, Inc. (CLBS)
CIK: 0000320017
Period of Report: 2016-10-25
Reporting Person: Mazzo David J (Director, Chief Executive Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-10-25 | Common Stock | F | 457 | $4.12 | Disposed | 47238 | Direct |
Footnotes
F1: Includes 15,468 shares of unvested restricted stock.